Isabel Álvarez-López
Biographic Data
| ID | 9580329 |
|---|---|
| NAME | Isabel Álvarez-López |
| GIVEN NAMES | Isabel |
| FAMILY NAME | Álvarez-López |
| SIGNATURE | ÁLVAREZ-LÓPEZ I |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component
To measure 3-year care costs of breast, prostate, colorectal and lung cancers disaggregated by site and clinical stage. A retrospective observational design was employed to investigate care costs of cases recorded in the Registry of the Basque Country between 2010 and 2015. Data gathered included TNM stage and demographic, clinical and resource use variables. Total costs per patient with stage IV disease were calculated by combining generalized l…
Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test
To carry out a cost-utility analysis of the application of the Oncotype genomic test to inform the decision to use or not to use chemotherapy in the Basque Country (Spain). The cost-utility study was carried out using a discrete event simulation model representing the natural history of breast cancer. The decision of treatment with chemotherapy based on Oncotype was compared with the standard of treatment based on clinical-pathological criteria. …
No prominent works on this page.
Probabilistic cost-utility analysis and expected value of perfect information for the Oncotype multigenic test
To carry out a cost-utility analysis of the application of the Oncotype genomic test to inform the decision to use or not to use chemotherapy in the Basque Country (Spain). The cost-utility study was carried out using a discrete event simulation model representing the natural history of breast cancer. The decision of treatment with chemotherapy based on Oncotype was compared with the standard of treatment based on clinical-pathological criteria. …
Health care costs of breast, prostate, colorectal and lung cancer care by clinical stage and cost component
To measure 3-year care costs of breast, prostate, colorectal and lung cancers disaggregated by site and clinical stage. A retrospective observational design was employed to investigate care costs of cases recorded in the Registry of the Basque Country between 2010 and 2015. Data gathered included TNM stage and demographic, clinical and resource use variables. Total costs per patient with stage IV disease were calculated by combining generalized l…
Economic and Financial Impacts of Cancer (2 works) · Gynecology (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Medicine (2 works) · BRCA gene mutations in cancer (1 works) · Breast cancer (1 works) · Cancer (1 works) · Cancer registry (1 works) · Colorectal cancer (1 works) · Cost effectiveness (1 works)